Skip to main content

Anti-cancer Drugs: Discovery, Development and Therapy

  • Chapter
International Manual of Oncology Practice

Abstract

The most widely used treatments for cancer are surgery, radiotherapy and chemotherapy. Chemotherapy is the only option for metastatic cancers, where the treatment has to be systemic. The most frequently used chemotherapy drugs have been identified empirically without any pre-existing knowledge regarding the molecular mechanism of action of the drugs. Despite the remarkable progress achieved in cancer care and research over the past several decades, the treatment options for the majority of epithelial cancers have not changed much. However, a critical mass of knowledge has been accumulated that may transform cancer treatments from cytotoxic regimens towards the rapidly dividing cells into personalized targeted therapies. This chapter will provide an overview of currently used chemotherapeutics and will explore the impact of the molecular understanding of cancer on modern drug discovery, drug development and cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. De Vita VT, Jrand CE (2008) A history of cancer chemo-therapy. Cancer Res 68:8643–8653

    Article  Google Scholar 

  2. Savage P, Stebbing J, Bower M, Crook T (2009) Why does cytotoxic chemotherapy cure only some cancers? Nat Clin Pract Oncol 6:43–52

    Article  PubMed  CAS  Google Scholar 

  3. Haber DA, Gray NS, Baselga J (2011) The evolving war on cancer. Cell 145:19–24

    Article  PubMed  CAS  Google Scholar 

  4. Gibbs JB (2000) Mechanism-based target identification and drug discovery in cancer research. Science 287:1969–1973

    Article  PubMed  CAS  Google Scholar 

  5. Benson JD, Chen YNP, Cornell-Kennon SA, Dorsch M, Kim S, Leszczyniecka M, Sellers WR, Lengauer C (2006) Validating cancer drug targets. Nature 441:451–456

    Article  PubMed  CAS  Google Scholar 

  6. Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1:493–502

    Article  PubMed  CAS  Google Scholar 

  7. Sawyers C (2004) Targeted cancer therapy. Nature 432:294–297

    Article  PubMed  CAS  Google Scholar 

  8. van’t Veer LJ, Bernards R (2008) Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452:564–570

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Link .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Link, W. (2015). Anti-cancer Drugs: Discovery, Development and Therapy. In: de Mello, R., Tavares, Á., Mountzios, G. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-21683-6_6

Download citation

Publish with us

Policies and ethics